Here’s the Bigger Story About Moderna That You Might Be Missing

Ask most people about Moderna (NASDAQ: MRNA) and you're likely to ... The biggest winners would be the stocks of companies that have a quick ...Want to know more on Here's the Bigger Story About Moderna That You Might Be Missing click here go to market news source. Market news summary from NonSell.com Best Stocks Pickup News.Author:

Better Coronavirus Stock: Gilead Sciences vs. Moderna

When the history books are written about the COVID-19 pandemic, two biotechs will almost certainly be included. Gilead Sciences (NASDAQ: GILD) became the first company to win emergency use authorization from the Food and Drug Administration for a new drug for treating COVID-19,Want to know more on Better Coronavirus Stock: Gilead Sciences vs. Moderna click here go to market news source. Market news summary from Nasdaq Market News.Author: The...

Germany Adds 11 Regions To “Coronavirus Watch List”, France Closes Bars, Restaurants In Marseilles: Live Updates

Germany Adds 11 Regions To "Coronavirus Watch List", France Closes Bars, Restaurants In Marseilles: Live Updates Tyler Durden Wed, 09/23/2020 - 19:28 Summary: Germany adds 11 regions to travel warning list France orders bars and restaurants shut in Marseilles, Paris on "high alert" Head of FDA advisory committee recuses herself from COVID vaccine review Irish outbreak worsens Eiffel Tower reopens, Met Opera scraps season CDC director hints at...

Head of the FDA vaccine advisory committee also overseeing clinical trial for Moderna COVID-19 candidate

The Chair of the FDA's Vaccines and Related Biological Products Advisory Committee - the panel of outside experts that will make recommendations on whether coronavirus vaccines should be approved has recused herself from the panel's review of COVID-19 vaccines. Want to know more on Head of the FDA vaccine advisory committee also overseeing clinical trial for Moderna COVID-19 candidate click here go to market news source. Market news summary...

Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict

A physician who heads the influential U.S. Food and Drug Administration vaccine advisory committee recused herself from the panel's review of COVID-19 vaccines because of her role overseeing a clinical trial for Moderna Inc's candidate, her spokeswoman told Reuters. Read More Want to know more on Top adviser steps aside from FDA COVID-19 vaccine reviews over potential conflict click here go to market news source. Market news summary...

Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccine

Sanofi and GlaxoSmithKline PLC announced Tuesday that the companies have signed agreements with Canada to supply up to 72 million doses of their COVID-19 vaccine, starting in 2021. The companies had initiated a Phase 1/2 study on their vaccine candidate on Sept. 3, and expect first results in early December to support the initiation of a Phase 3 study before the end of the year. The companies said...

Forget Moderna — This Is a Stronger Coronavirus Stock

The coronavirus pandemic has plagued countries around the world since late 2019, with no end in sight. Biotech companies are now in a frantic race to develop a vaccine against SARS-CoV-2, the novel coronavirus that has contributed to the deaths of over 200,000 people in the U.S.Want to know more on Forget Moderna -- This Is a Stronger Coronavirus Stock click here go to market news source. Market...

Duterte assures Filipinos: PH will be better off by January with vaccine breakthrough

The country is like a ship dead in the water but will hopefully be “better off” by January once the coronavirus vaccine is developed, President Duterte declared Monday night. President Rodrigo Roa Duterte talks to the people after holding a meeting with the Inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID) core members at the Arcadia Active Lifestyle Center in Davao City on September 21, 2020. (ALBERTO...
Close

Market News Language